Fidelity Disrupt Medicin ETFFMEDETF
13F holders, Q2 2025 (June 30)7holders +1
1new positions
0sold out
$23.98avg. 13F price*
At the end of Q2 2025, 7 institutions reported holding Fidelity Disrupt Medicin ETF (FMED) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were FMR LLC ($17.6M), Wealth Enhancement Advisory Services, LLC ($16.5M) and Jane Street Group, LLC ($494K).
- Company
- Fidelity Disrupt Medicin ETF
- CUSIP
- 316092147
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 172,372 shares bought and 45,755 shares sold, net +126,617 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| FMR LLC | 0.00% | Add +14.9% | 733,038 | $17.6M |
| Wealth Enhancement Advisory Services, LLC | 0.03% | Add +12.5% | 688,750 | $16.5M |
| Jane Street Group, LLC | 0.00% | Reduce -68.9% | 20,627 | $494K |
| Park Square Financial Group, LLC | 0.01% | No change | 589 | $14K |
| UBS Group AG | 0.00% | New | 584 | $14K |
| Central Pacific Bank - Trust Division | 0.00% | No change | 97 | $2K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 90 | $2K |
"% of holder's portfolio" is FMED's weight in each manager's 13F, not the share of Fidelity Disrupt Medicin ETF the manager owns.